Enhanced Immunogenicity of HIV-1 Vaccine Construct by Modification of the Native Peptide Sequence

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.94.20.10856
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

The Safety and Immunogenicity of an Interleukin-12–Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2016English

Enhanced Immunogenicity of a Bivalent Nicotine Vaccine

International Immunopharmacology
AllergyImmunologyPharmacology
2008English

Peptide Adjacent to Glycosylation Sites Impacts Immunogenicity of Glycoconjugate Vaccine

Oncotarget
Oncology
2017English

HIV-1 Glycoprotein Immunogenicity

2011English

Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B

Vaccines
Drug DiscoveryInfectious DiseasesImmunologyPharmacology
2020English

Safety and Immunogenicity of a Gag-Pol Candidate HIV-1 DNA Vaccine Administered by a Needle-Free Device in HIV-1-Seronegative Subjects

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2007English

492. An Enhanced DC-Targeting Lentivector Vaccine to HIV-1 Gag by PD-1 Blockade

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2011English

Effect of Plasmid Backbone Modification by Different Human CpG Motifs on the Immunogenicity of DNA Vaccine Vectors

Journal of Leukocyte Biology
AllergyImmunologyCell Biology
2005English

Induction of Broad Cross-Subtype-Specific HIV-1 Immune Responses by a Novel Multivalent HIV-1 Peptide Vaccine in Cynomolgus Macaques

Journal of Immunology
AllergyImmunology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy